RBM3 protein in colorectal cancer prognostics

Details for Australian Patent Application No. 2010212764 (hide)

Owner Atlas Antibodies AB

Inventors Uhlen, Mathias; Ponten, Fredrik; Jirstrom, Karin

Agent Pizzeys

Pub. Number AU-A-2010212764

PCT Pub. Number WO2010/092182

Priority 09158084.5 16.04.09 EP; 61/169,963 16.04.09 US; 09167847.4 13.08.09 EP; 61/233,769 13.08.09 US; PCT/ EP2009/067419 17.12.09 EP; PCT/ SE2009/000091 16.02.09 SE

Filing date 16 February 2010

Wipo publication date 19 August 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/092182 Priority application(s): WO2010/092182

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212769-RBM3 protein in testicular cancer diagnostics and prognostics

2010212763-Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1